PROTHENA CORP PUBLIC LTD CO (PRTA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 4,420 | 2,828 | 970 | 132,014 |
| Restructuring costs | 32,609 | - | - | - |
| Research and development | 40,517 | 50,811 | 50,723 | 57,510 |
| General and administrative | 15,910 | 17,598 | 16,760 | 16,127 |
| Total operating expenses | 89,036 | 68,409 | 67,483 | 73,637 |
| Income (loss) from operations | -84,616 | -65,581 | -66,513 | 58,377 |
| Other expense, net | -143 | -140 | -66 | -51 |
| Interest income | 3,794 | 4,348 | 6,743 | 6,521 |
| Total other income, net | 3,651 | 4,208 | 6,677 | 6,470 |
| Income (loss) before income taxes | -80,965 | -61,373 | -59,836 | 64,847 |
| Provision for (benefit from) income taxes | 44,802 | -1,178 | -835 | -2,039 |
| Net income (loss) | -125,767 | -60,195 | -59,001 | 66,886 |
| Basic (in dollars per share) | -2.34 | -1.12 | -1.1 | 1.24 |
| Diluted (in dollars per share) | -2.34 | -1.12 | -1.1 | 1.22 |
| Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) | 53,827,000 | 53,827,000 | 53,790,000 | 53,767,000 |
| Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) | 53,827,000 | 53,827,000 | 53,790,000 | 55,043,000 |